stoxline Quote Chart Rank Option Currency Glossary
  
Agilon Health, Inc. (AGL)
0.9866  0.01 (1.01%)    01-21 10:20
Open: 0.9932
High: 0.9932
Volume: 450,653
  
Pre. Close: 0.9767
Low: 0.9602
Market Cap: 409(M)
Technical analysis
2026-01-21 9:14:02 AM
Short term     
Mid term     
Targets 6-month :  1.22 1-year :  1.42
Resists First :  1.04 Second :  1.22
Pivot price 0.86
Supports First :  0.8 Second :  0.65
MAs MA(5) :  0.98 MA(20) :  0.82
MA(100) :  0.88 MA(250) :  2.13
MACD MACD :  0 Signal :  0
%K %D K(14,3) :  89.9 D(3) :  91.2
RSI RSI(14): 65
52-week High :  6.07 Low :  0.5
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ AGL ] has closed below upper band by 28.0%. Bollinger Bands are 92.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1 - 1.01 1.01 - 1.01
Low: 0.94 - 0.95 0.95 - 0.95
Close: 0.97 - 0.98 0.98 - 0.99
Company Description

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Headline News

Wed, 21 Jan 2026
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of agilon health, inc.(AGL) Shareholders - morningstar.com

Tue, 20 Jan 2026
AGL SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on - GlobeNewswire

Tue, 20 Jan 2026
Shareholder Rights Law Firm Robbins LLP Urges Agilon Health, Inc. Stockholders to Seek Information About Their Rights Against AGL - The AI Journal

Tue, 20 Jan 2026
Agilon Health Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of agilon health, inc. - AGL - PR Newswire

Tue, 20 Jan 2026
Deadline Alert: agilon health, inc. (AGL) Shareholders Who - GlobeNewswire

Mon, 19 Jan 2026
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Agilon (AGL) Investors of Pending Class Action Lawsuit - TMX Newsfile

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Care Facilities
Shares Out 415 (M)
Shares Float 269 (M)
Held by Insiders 2 (%)
Held by Institutions 92.8 (%)
Shares Short 19,390 (K)
Shares Short P.Month 17,930 (K)
Stock Financials
EPS -0.78
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.74
Profit Margin -5.3 %
Operating Margin -8.9 %
Return on Assets (ttm) -12.6 %
Return on Equity (ttm) -73.4 %
Qtrly Rev. Growth -1.2 %
Gross Profit (p.s.) -0.26
Sales Per Share 14.2
EBITDA (p.s.) -0.83
Qtrly Earnings Growth 0 %
Operating Cash Flow -69 (M)
Levered Free Cash Flow -23 (M)
Stock Valuations
PE Ratio -1.26
PEG Ratio 0
Price to Book value 1.31
Price to Sales 0.06
Price to Cash Flow -5.89
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android